David A. Palma
Advanced in Lung Metastases

David A. Palma

London, ON, CA 
Advanced in Lung Metastases
London, ON, CA 
OverviewLocationsClinical Research

Overview

David Palma practices in London, Canada. Mr. Palma is rated as an Advanced expert by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngectomy, and Cardiac Ablation.

His clinical research consists of co-authoring 329 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Lung Metastases.

Gender
Male

Locations

London, ON, Canada
Other Locations
London, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Drug, Other, Radiation
Study Phase: Phase 3
SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial
SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Radiation
Study Phase: Phase 1
Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease (ASPIRE-ILD): A Phase II Trial
Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease (ASPIRE-ILD): A Phase II Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
A Randomized Study of Vocal-cord Only vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
A Randomized Study of Vocal-cord Only vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 21, 2025
Intervention Type: Radiation
Study Phase: Phase 2
Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer: A Randomized Clinical Trial
Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer: A Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Drug
Study Drugs: Opioids, Pregabalin, Acetaminophen, Naproxen, Pantoprazole magnesium
Study Phase: Phase 2
A Randomized Trial of Treatment De-Escalation for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: Radiotherapy vs. Trans-Oral Surgery (ORATOR II)
A Randomized Trial of Treatment De-Escalation for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: Radiotherapy vs. Trans-Oral Surgery (ORATOR II)
Enrollment Status: Active_not_recruiting
Publish Date: October 05, 2023
Intervention Type: Procedure, Radiation
Study Phase: Not Applicable
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial): A Randomized Phase II Trial
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial): A Randomized Phase II Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2023
Intervention Type: Radiation, Other
Study Phase: Not Applicable
A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)
A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)
Enrollment Status: Unknown
Publish Date: March 08, 2023
Intervention Type: Procedure, Radiation
Study Phase: Phase 2
Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial
Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial
Enrollment Status: Terminated
Publish Date: September 25, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 8 Less Clinical Trials

329 Total Publications

Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial.
Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial.
Journal: International journal of radiation oncology, biology, physics
Published: June 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Palma's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile